Apollomics, Inc. (NASDAQ:APLMW) Short Interest Up 238.5% in September

Apollomics, Inc. (NASDAQ:APLMW) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totalling 58,900 shares, a growth of 238.5% from the September 15th total of 17,400 shares. Based on an average daily volume of 21,600 shares, the short-interest ratio is currently 2.7 days.

Apollomics Stock Performance

Shares of NASDAQ:APLMW remained flat at $0.01 during trading on Friday. The firm has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.02. Apollomics has a 52 week low of $0.01 and a 52 week high of $0.10.

About Apollomics

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.